CART Neurons
Introduction <table class="infobox infobox-cell">Category </td>Location </td>Cell Types </td>Primary Neurotransmitter </td>Key Markers </td>
Cocaine- and amphetamine-regulated transcript (CART) neurons represent a major neuromodulatory system in the central nervous system, widely distributed across brain regions involved in energy homeostasis, reward processing, stress responses, and neuroprotection. CART peptides, derived from the CARTPT gene, act as neurotransmitters and neuropeptides with widespread physiological effects relevant to neurodegenerative disease pathogenesis. [@koylu1998]
Overview
Anatomy and Distribution
Brain Region Distribution CART neurons are densely concentrated in:
...
CART Neurons
Introduction <table class="infobox infobox-cell">Category </td>Location </td>Cell Types </td>Primary Neurotransmitter </td>Key Markers </td>
Cocaine- and amphetamine-regulated transcript (CART) neurons represent a major neuromodulatory system in the central nervous system, widely distributed across brain regions involved in energy homeostasis, reward processing, stress responses, and neuroprotection. CART peptides, derived from the CARTPT gene, act as neurotransmitters and neuropeptides with widespread physiological effects relevant to neurodegenerative disease pathogenesis. [@koylu1998]
Overview
Anatomy and Distribution
Brain Region Distribution CART neurons are densely concentrated in:
Hypothalamus : Arcuate nucleus (ARC), paraventricular nucleus (PVN), lateral hypothalamic area (LHA)Amygdala : Central nucleus, basolateral amygdalaCortex : Prefrontal cortex, piriform cortexHippocampus : CA regions, dentate gyrusBrainstem : Dorsal raphe nucleus, locus coeruleus, nucleus tractus solitariusCellular Morphology CART neurons exhibit:
Small to medium-sized cell bodies (15-25 μm diameter)
Extensive dendritic arborization
Axonal projections to target regions
Co-localization with other neuropeptides (POMC, NPY, orexin)
Molecular Biology
Gene and Peptide Structure The CARTPT gene encodes prepro-CART, which is processed into active peptides:
CART (55-102): Major active form
CART (62-102): Alternative processing product
Molecular weight: ~5-10 kDa
Receptors CART signaling occurs through:
Unknown receptor(s) : Primary signaling mechanism remains incompletely characterizedPotential GPCR interactions : Evidence for G-protein coupled signalingIntracellular pathways : cAMP, MAPK, PI3K signaling cascadesFunction
Energy Homeostasis CART neurons play critical roles in metabolic regulation:
Appetite suppression : Potent anorexigenic signalsLeptin interaction : Downstream of leptin signalingMelanocortin pathway : Modulates melanocortin-4 receptor activityEnergy expenditure : Increases metabolic rateReward and Addiction In mesolimbic circuits:
VTA projections : CART in ventral tegmental area dopamine neuronsNucleus accumbens : Modulates reward learningCocaine/amphetamine effects : Regulated by psychostimulantsNatural rewards : Food reward processingStress Response CART modulates hypothalamic-pituitary-adrenal (HPA) axis:
CRH interaction : Modulates corticotropin-releasing hormone neuronsAnxiety behaviors : Anxiogenic effects in stress paradigmsAdaptive responses : Stress-induced upregulationNeuroprotection Emerging evidence for neuroprotective functions:
Anti-apoptotic effects : Reduces caspase activationOxidative stress : Antioxidant propertiesExcitotoxicity : Modulates glutamate toxicityNeuroinflammation : Anti-inflammatory actionsRole in Neurodegenerative Diseases
Alzheimer's Disease CART neurons may influence AD pathogenesis through:
Amyloid interaction : Modulates Aβ toxicityTau pathology : Effects on tau phosphorylationCholinergic system : Interactions with basal forebrain cholinergic neuronsMetabolic dysfunction : Energy homeostasis disruptionParkinson's Disease In PD:
Dopaminergic protection : Potential preservation of SNc neuronsLewy body pathology : Relationship to α-synucleinMotor control : Non-motor symptoms (autonomic dysfunction)Other Neurodegenerative Conditions
Huntington's disease : CAG repeat pathologyALS : Motor neuron vulnerabilityStroke : Ischemic injury responsesClinical Significance
Therapeutic Targets CART-based interventions for:
Obesity : CART agonists for appetite suppressionAddiction : CART modulation in substance use disordersDepression : Anxiolytic strategiesNeuroprotection : Disease-modifying approachesBiomarker Potential CART as potential biomarker:
CSF levels : Cerebrospinal fluid measurementsPeripheral markers : Blood-based indicatorsDisease progression : Correlations with severityResearch Methods
Detection Techniques
Immunohistochemistry : CART antibody stainingIn situ hybridization : CARTPT mRNA localizationElectrophysiology : Optogenetic manipulationCalcium imaging : Activity monitoringAnimal Models
Knockout mice : CART-deficient modelsTransgenic lines : Reporter linesViral vectors : Cre-dependent expressionBrain Atlas Resources
[Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
[Allen Cell Type Atlas](https://celltypes.brain-map.org/) - Single-cell expression data
[Allen Mouse Brain Atlas](https://mouse.brain-map.org/) - Mouse brain reference data](/datasets/mouse-brain-atlas)
[Allen Human Brain Atlas](https://human.brain-map.org/microarray) - Gene expression data
External Links
[Cell Type Database](https://portal.brain-map.org/)
[PubMed: Cell Type Markers](https://pubmed.ncbi.nlm.nih.gov/)
Pathway Diagram The following diagram shows the key molecular relationships involving CART Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)
Show full description